Author: Mary-Louise Hoffman|| Date Published: July 12, 2022
Three companies and two nonprofit organizations have won spots on a potential 10-year, $320 million contract to support epidemiology and genetics research at the National Cancer Institute.
Work under the indefinite-delivery/indefinite-quantity contract involves field preparation, biospecimen collection and clinical assistance to NCI’s Division of Cancer Epidemiology and Genetics, according to an award notice posted on SAM.gov.
A prior solicitation notice stated that the multiple-award procurement could support approximately 150 scientists across DCEG, which conducts large-scale public health studies with the goal of uncovering the causes of cancer.
The awardees are:
American Type Culture Collection
Coriell Institute for Medical Research
ICF (Nasdaq: ICFI)
Social & Scientific Systems, a subsidiary of DLH Holdings (Nasdaq: DLHC)
Lockheed Martin has received a $249 million indefinite-delivery/indefinite-quantity contract from the U.S. Navy to support the Surface Electronic Warfare Improvement Program,…
Qualis, InTrack Radar Technologies and Tektonux have merged to form a single company focused on modernizing missile defense, space domain awareness, integrated fires…
